Related Experiment Videos
[Chronobiologic aspects of therapy for cardiovascular diseases]
1Zakład Farmakologii Klinicznej, Akademii Medycznej, Lodzi.
Insights
This study explores the time-dependent nature of cardiovascular events, highlighting their triggers and the role of chronotherapy. It reviews circadian and seasonal variations in heart attacks, angina, sudden cardiac death, and stroke, along with chronopharmacological treatments.
Area of Science:
- Cardiology
- Chronobiology
- Pharmacology
Context:
- Cardiovascular diseases exhibit significant diurnal and seasonal variations.
- Understanding these time-dependent patterns is crucial for effective disease management.
- Incidents like myocardial infarction, angina, stroke, and sudden cardiac death show predictable temporal fluctuations.
Purpose:
- To present chronobiological considerations of cardiovascular disease.
- To discuss triggering mechanisms and their role in chronotherapy.
- To review chronopharmacological approaches for coronary heart disease and hypertension.
Summary:
- The article details the time-dependent incidence of cardiovascular diseases, including triggering factors and their implications for chronotherapy.
- It highlights demonstrated circadian and seasonal variations in myocardial infarction, angina pectoris, sudden cardiac death, and stroke.
- Chronopharmacological aspects of treating coronary heart disease and hypertension are also examined.
Impact:
- Provides insights into optimizing treatment timing for cardiovascular conditions.
- Emphasizes the importance of chronobiology in understanding and managing heart disease.
- Informs the development of chronotherapy strategies for improved patient outcomes.
Abstract:
A chronobiological considerations of time-dependent incidents of cardiovascular diseases including triggering mechanisms and their role in chronotherapy are presented in the article. Circadian and seasonal variation has been demonstrated especially in myocardial infarction, stable and unstable angina pectoris, sudden cardiac death and stroke. Chronopharmacological considerations of therapy of coronary heart disease and hypertension are also reviewed.